BridgeBio Pharma (BBIO) Minority Interest (2017 - 2026)

BridgeBio Pharma's Minority Interest history runs 10 years deep, the most recent figure standing at $10.4 million for Q1 2026.

• In Q1 2026, Minority Interest rose 4.84% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (up 4.84% YoY), while the FY2025 annual figure was $10.6 million, up 4.42% from the prior year.
• Minority Interest came in at $10.4 million for Q1 2026 at BridgeBio Pharma, down from $10.6 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $12.4 million in Q3 2023 to a low of -$27000.0 in Q1 2022.
• A 5-year average of $10.4 million and a median of $10.9 million in 2024 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest slumped 102.12% in 2022 and soared 45492.59% in 2023, its largest moves.
• BridgeBio Pharma's Minority Interest stood at $11.3 million in 2022, then dropped by 0.34% to $11.2 million in 2023, then dropped by 9.73% to $10.2 million in 2024, then rose by 4.42% to $10.6 million in 2025, then dropped by 1.51% to $10.4 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered $10.4 million, $10.6 million, and $10.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison